Micro Cap Biotech Secures $60M to Advance Alzheimer's Treatment, Shares Surge [Globe and Mail, The (Toronto, Canada)]
VACCINEX INC (VCNX)
Company Research
Source: Globe and Mail, The
It progressively damages brain cells through the buildup of abnormal proteins (known as plaques and tangles) which destroy neurons and interfere with communication throughout the brain. Developing effective prevention or treatment remains extremely challenging because Alzheimer's is driven by multiple interacting factors, including inflammation, genetics, and possibly infections, rather than a single cause. In addition, many therapies struggle to reach the brain due to its natural protective barrier. For these reasons, any meaningful advancement in Alzheimer's research attracts significant attention from both scientists and investors. Today, one micro-cap company captured headlines as it continues its effort to potentially bring relief to millions of patients affected by this devastating disease. Vaccinex, Inc. (OTCPK: VCNX) announced a $60 million revenue-sharing agreement with Pepinemab Development Venture, LP (PDV) to fund an expanded Phase 2b clinical trial of pepinemab for th
Show less
Read more
Impact Snapshot
Event Time:
VCNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCNX alerts
High impacting VACCINEX INC news events
Weekly update
A roundup of the hottest topics